Battelle Memorial Institute

Thomas O Metz

Richard Dale Smith

Jon Morrell Jacobs

David G Camp, Ii

Qibin Zhang

Weijun Qian

Wei-Jun Qian

Ashoka D Polpitiya

A method for identifying persons with increased risk of developing type 1 diabetes mellitus, or having type I diabetes mellitus, utilizing selected biomarkers described herein either alone or in combination. The present disclosure allows for broad based, reliable, screening of large population bases. Also provided are arrays and kits that can be used to perform such methods.

Peptide and protein biomarkers for type 1 diabetes mellitus

A method for identifying persons with increased risk of developing type 2 diabetes mellitus utilizing selected biomarkers described hereafter either alone or in combination. The present invention allows for broad based, reliable, screening of large population bases and provides other advantages, including the formulation of effective strategies for characterizing, archiving, and contrasting data from multiple sample types under varying conditions.

Serum markers for type II diabetes mellitus

A method and system for classifying subject populations utilizing predictive and diagnostic biomarkers for type I diabetes mellitus. The method including determining the levels of a variety of markers within the serum or plasma of a target organism and correlating this level to general populations as a screen for predisposition or progressive monitoring of disease presence or predisposition.

Method for identifying type I diabetes mellitus in humans

Growing community of inventors

Kennewick, WA, United States of America

Thomas O Metz